1. Home
  2. SHOP vs AMGN Comparison

SHOP vs AMGN Comparison

Compare SHOP & AMGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shopify Inc.

SHOP

Shopify Inc.

HOLD

Current Price

$156.08

Market Cap

222.4B

Sector

Technology

ML Signal

HOLD

Logo Amgen Inc.

AMGN

Amgen Inc.

HOLD

Current Price

$331.17

Market Cap

181.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOP
AMGN
Founded
2004
1980
Country
Canada
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.4B
181.7B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
SHOP
AMGN
Price
$156.08
$331.17
Analyst Decision
Buy
Hold
Analyst Count
32
14
Target Price
$167.48
$321.69
AVG Volume (30 Days)
5.5M
2.7M
Earning Date
02-10-2026
02-03-2026
Dividend Yield
N/A
3.05%
EPS Growth
28.16
65.12
EPS
1.36
12.93
Revenue
$10,696,000,000.00
$35,971,000,000.00
Revenue This Year
$31.82
$10.82
Revenue Next Year
$23.79
$1.73
P/E Ratio
$114.96
$25.55
Revenue Growth
30.25
10.56
52 Week Low
$69.84
$261.43
52 Week High
$182.19
$346.38

Technical Indicators

Market Signals
Indicator
SHOP
AMGN
Relative Strength Index (RSI) 41.76 53.38
Support Level $153.78 $319.79
Resistance Level $170.90 $343.05
Average True Range (ATR) 6.11 7.18
MACD -1.39 -0.07
Stochastic Oscillator 14.60 53.95

Price Performance

Historical Comparison
SHOP
AMGN

About SHOP Shopify Inc.

Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.

About AMGN Amgen Inc.

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Share on Social Networks: